Around 80 jobs are under threat at a company that makes products to treat diabetes.
Staff at LifeScan Scotland in Inverness were told by management on Tuesday that their positions are at risk.
The company, which is owned by Johnson & Johnson (J&J) says it is pressing ahead with a planned £8.7m investment despite uncertainty over J&J’s future in diabetes research.
LifeScan was given £1.85m by Highlands and Islands Enterprise last year to support the plan.
It received another £2m in 2009 to safeguard 200 jobs.
J&J spokeswoman Donna Lorenson said: “The proposed actions today in Scotland are part of a global business reorganisation that will impact approximately 350 roles around the world including approximately 80 in Scotland, pending the outcome of the consultation process.
“Evaluations like these help ensure our business can adapt to the changing market environment and meet the needs of customers and patients.”
LifeScan employs around 1100 people.